Pfizer Inc.
New firms spun off from larger companies sometimes rise quickly, like Carrier and Otis. That’s probably because investors are familiar with their products and like their prospects. However, others such as Viatris and Kyndryl, are more obscure and need a few years to build a following....
PFIZER INC. $49 is a buy. The prescription drugmaker (New York symbol PFE; Manufacturing & Industry sector; Shares outstanding: 5.6 billion; Market cap: $274.4 billion; Dividend yield: 3.3%; Takeover Target Rating: Medium; www.pfizer.com) merged its consumer drug business with GlaxoSmithKline (New York symbol GSK) in 2019.
Glaxo now plans to spin off this business as a separate firm called Haleon; it owns 68% of this operation, with Pfizer holding the remaining 32%....
Glaxo now plans to spin off this business as a separate firm called Haleon; it owns 68% of this operation, with Pfizer holding the remaining 32%....
CANADIAN TIRE CORP., $161.80, Toronto symbol CTC.A, is a buy.
Investors tap the company’s 504 Canadian Tire stores. They sell automotive parts and services, and household and sporting goods; franchisees run most of the locations. Still, the company’s other operations also enrich its outlook....
Investors tap the company’s 504 Canadian Tire stores. They sell automotive parts and services, and household and sporting goods; franchisees run most of the locations. Still, the company’s other operations also enrich its outlook....
Pharmaceutical giant GlaxoSmithKline recently rejected a takeover offer from Unilever for its consumer drug business and will continue with its original plan to spin it off as a separate company.
The spinoff will let Glaxo better focus on its main prescription drug and vaccine operations....
The spinoff will let Glaxo better focus on its main prescription drug and vaccine operations....
PFIZER INC., $49.92, New York symbol PFE, is your #1 Income Buy for 2022.
The company is one of the world’s largest makers of prescription drugs. Its top-selling brands include Lyrica (epilepsy), Celebrex and Enbrel (arthritis), and Prevnar (pneumonia).
Pfizer has raised its dividend rate each year since 2011....
The company is one of the world’s largest makers of prescription drugs. Its top-selling brands include Lyrica (epilepsy), Celebrex and Enbrel (arthritis), and Prevnar (pneumonia).
Pfizer has raised its dividend rate each year since 2011....
PFIZER INC., $49.04, New York symbol PFE, is your #1 Income Buy for 2022.
The company is one of the world’s largest makers of prescription drugs. Its top-selling brands include Lyrica (epilepsy), Celebrex and Enbrel (arthritis), and Prevnar (pneumonia).
Pfizer has raised its dividend rate each year since 2011....
The company is one of the world’s largest makers of prescription drugs. Its top-selling brands include Lyrica (epilepsy), Celebrex and Enbrel (arthritis), and Prevnar (pneumonia).
Pfizer has raised its dividend rate each year since 2011....
ROYAL BANK OF CANADA, $136.66, Toronto symbol RY, is a buy.
Royal raised your quarterly dividend by 11.1% with the February 2022 payment. Investors now receive $1.20 a share instead of $1.08. The new annual rate of $4.80 yields 3.5%. The bank also plans to repurchase roughly 3.16% of its common shares over the next year.
The bank has now agreed to buy U.K.-based wealth management firm Brewin Dolphin Holdings Plc....
Royal raised your quarterly dividend by 11.1% with the February 2022 payment. Investors now receive $1.20 a share instead of $1.08. The new annual rate of $4.80 yields 3.5%. The bank also plans to repurchase roughly 3.16% of its common shares over the next year.
The bank has now agreed to buy U.K.-based wealth management firm Brewin Dolphin Holdings Plc....
PFIZER INC., $51.57, New York symbol PFE, is your #1 Income Buy for 2022.
The company is one of the world’s largest makers of prescription drugs. Its top-selling brands include Eliquis (stroke), Ibrance (breast cancer) and Prevnar (pneumonia).
Pfizer has increased its dividend rate each year since 2011....
The company is one of the world’s largest makers of prescription drugs. Its top-selling brands include Eliquis (stroke), Ibrance (breast cancer) and Prevnar (pneumonia).
Pfizer has increased its dividend rate each year since 2011....
New spinoffs often struggle for a period, partly because investors tend to dump their new shares. We think that’s why Kyndryl and Viatris are down since they became separate companies. Still, we believe both will eventually move higher, and we see each of them as a hold.
KYNDRYL HOLDINGS INC....
KYNDRYL HOLDINGS INC....
RAYTHEON TECHNOLOGIES CORP., $99.59, New York symbol RTX, is a buy for long-term gains.
The company took its current form on April 3, 2020, with the merger of United Technologies Corp. (old symbol UTX) and Raytheon Co. (old symbol RTN). It’s now a leading maker of commercial aircraft equipment, electronic systems for military aircraft and radar systems, and guided missiles.
The stock hit a new all-time high of $104.34 this week in response to Russia’s invasion of Ukraine....
The company took its current form on April 3, 2020, with the merger of United Technologies Corp. (old symbol UTX) and Raytheon Co. (old symbol RTN). It’s now a leading maker of commercial aircraft equipment, electronic systems for military aircraft and radar systems, and guided missiles.
The stock hit a new all-time high of $104.34 this week in response to Russia’s invasion of Ukraine....